Balyasny Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.74M | Buy |
329,073
+157,949
| +92% | +$2.76M | 0.01% | 844 |
|
|
2025
Q1 | $2.15M | Sell |
171,124
-173,817
| -50% | -$2.19M | ﹤0.01% | 1139 |
|
|
2024
Q4 | $3.64M | Buy |
344,941
+322,423
| +1,432% | +$3.4M | 0.01% | 936 |
|
|
2024
Q3 | $327K | Sell |
22,518
-3,817
| -14% | -$55.3K | ﹤0.01% | 1683 |
|
|
2024
Q2 | $224K | Sell |
26,335
-4,106
| -13% | -$34.9K | ﹤0.01% | 1680 |
|
|
2024
Q1 | $311K | Buy |
30,441
+13,002
| +75% | +$133K | ﹤0.01% | 1644 |
|
|
2023
Q4 | $95.6K | Buy |
+17,439
| New | +$95.6K | ﹤0.01% | 1817 |
|
|
2023
Q1 | – | Sell |
-11,328
| Closed | -$96.6K | – | 2612 |
|
|
2022
Q4 | $96.6K | Buy |
+11,328
| New | +$96.6K | ﹤0.01% | 1816 |
|